New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
ICC Rates Melbourne Cricket Ground Pitch 'Unsatisfactory' After Boxing Day Test Ends In 2 Days
'Terrible Ethics': Ekta Kapoor Slams Zee TV's New 'Pavitra Rishta', Calls Title Reuse An 'Intellectual Bankruptcy'
Arvind Fashions To Acquire Flipkart’s 31.25% Stake In Arvind Youth Brands For ₹135 Crore
Kerala Lottery Result Live, December 29, 2025: Check Full List Of Winners For Bhagyathara BT-35 Monday Lucky Draw; 1st Prize ₹1 Crore!
